The Insides News- The Insides Neo - fistuloclysis, distal feeding, best, alternative to parenteral nutrition, fistula, ostomy, ileostomy, chyme, enteral, oral nutrition, enteromate, intestinal failure, colon cancer, bowel cancer, gut cancer, ostomy appliance, high output, chyme, dehydration, defunctioned, ileus, lars, microbiome, lower interior resection syndrome, incontinent, incontinence, gut health, reversal surgery
The Insides Company Named as One of the First Companies in the Sir Paul Callaghan 100 Report

The Insides Company Named as One of the First Companies in the Sir Paul Callaghan 100 Report

July 17, 2023

Press Release

Source:The Insides Company Limited

On:17th July 2023

Companies:The Insides® Company Limited, Callaghan Innovation

The Insides Company has been named one of the first 16 companies in the Sir Paul Callaghan Top 100 Report. This report recognises world-leading New Zealand companies making a difference in Aotearoa, New Zealand, encapsulating Sir Paul Callaghan’s famous words:“One hundred inspired New Zealand entrepreneurs can turn this country around. That is the challenge for us all.”

Since its founding in 2017, The Insides Company has benefited from our long-standing relationship with Callaghan Innovation, from their early research & development programs to targeted business mentoring and dedicated Innovation IP support. The launch of the HealthTech Activator in recent years has also strengthened the connectivity of New Zealand’s medical technologies ecosystem and further accelerated the growth of our company.

Garth Sutherland, CEO of The Insides Company, said, “Callaghan Innovation has been instrumental in our product development and commercialisation journey by connecting us with experts and professionals in the field. We are grateful for their continuous support and commitment to helping world-leading innovations”.

About Callaghan Innovation

Callaghan Innovation, Aotearoa New Zealand’s innovation agency, catalyses the commercialisation of science, engineering, technology, and design in New Zealand. They partner with businesses of all sizes, providing a range of innovation and research and development services to suit each growth stage. Callaghan Innovation also enhances the operation of New Zealand’s innovation ecosystem, working closely with government partners, Crown Research Institutes, and other organisations that help increase business investment in R&D and innovation.

About The Insides Company

The Insides Company has commercialised 30 years of clinical experience in gut nutrition into breakthrough medical devices. The Insides Company’s mission is to provide universal access to chyme reinfusion therapy through revolutionary products and education to establish a new standard of care.


The Insides® Company Limited

Garth Sutherland, CEO

Phone:+64 9 887 9309

Choose Your Language

Selecting language below will change the language for